Phreesia (NYSE:PHR) Stock Price Up 10%

Phreesia, Inc. (NYSE:PHRGet Rating) shares rose 10% on Friday . The stock traded as high as $19.55 and last traded at $19.49. Approximately 4,136 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 766,016 shares. The stock had previously closed at $17.72.

PHR has been the subject of several recent research reports. Canaccord Genuity Group reduced their target price on shares of Phreesia from $81.00 to $49.00 in a research note on Thursday, March 31st. JPMorgan Chase & Co. dropped their target price on shares of Phreesia from $51.00 to $42.00 in a research report on Thursday, March 31st. Needham & Company LLC dropped their target price on shares of Phreesia from $65.00 to $35.00 and set a “buy” rating for the company in a research report on Thursday, March 31st. Robert W. Baird decreased their price target on shares of Phreesia from $51.00 to $35.00 and set an “outperform” rating on the stock in a research note on Friday, June 3rd. Finally, Royal Bank of Canada decreased their target price on shares of Phreesia from $29.00 to $20.00 in a research note on Monday, June 6th. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $44.00.

The firm has a market capitalization of $1.05 billion, a PE ratio of -6.26 and a beta of 1.39. The company has a debt-to-equity ratio of 0.02, a quick ratio of 4.93 and a current ratio of 4.93. The stock’s 50-day simple moving average is $20.94 and its 200-day simple moving average is $29.83.

Phreesia (NYSE:PHRGet Rating) last announced its earnings results on Thursday, June 2nd. The company reported ($0.99) EPS for the quarter, beating analysts’ consensus estimates of ($1.09) by $0.10. Phreesia had a negative net margin of 69.40% and a negative return on equity of 36.36%. The firm had revenue of $63.35 million for the quarter, compared to analysts’ expectations of $62.24 million. During the same quarter in the previous year, the business posted ($0.24) EPS. The company’s quarterly revenue was up 31.2% on a year-over-year basis. As a group, analysts predict that Phreesia, Inc. will post -3.95 earnings per share for the current fiscal year.

In other news, General Counsel Allison C. Hoffman sold 3,909 shares of the business’s stock in a transaction on Monday, May 9th. The shares were sold at an average price of $17.07, for a total transaction of $66,726.63. Following the sale, the general counsel now owns 115,099 shares in the company, valued at approximately $1,964,739.93. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 5.50% of the company’s stock.

A number of institutional investors have recently made changes to their positions in the stock. BlackRock Inc. boosted its stake in Phreesia by 5.8% in the 1st quarter. BlackRock Inc. now owns 6,359,641 shares of the company’s stock worth $167,640,000 after purchasing an additional 349,301 shares in the last quarter. Vanguard Group Inc. boosted its stake in Phreesia by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 3,510,495 shares of the company’s stock worth $92,536,000 after purchasing an additional 44,021 shares in the last quarter. Credit Suisse AG boosted its stake in Phreesia by 11.3% in the 4th quarter. Credit Suisse AG now owns 1,763,523 shares of the company’s stock worth $73,468,000 after purchasing an additional 179,222 shares in the last quarter. Brown Advisory Inc. boosted its stake in Phreesia by 27.4% in the 1st quarter. Brown Advisory Inc. now owns 1,649,403 shares of the company’s stock worth $43,680,000 after purchasing an additional 354,378 shares in the last quarter. Finally, Echo Street Capital Management LLC boosted its stake in Phreesia by 254.5% in the 1st quarter. Echo Street Capital Management LLC now owns 1,207,228 shares of the company’s stock worth $31,823,000 after purchasing an additional 866,654 shares in the last quarter. Institutional investors own 94.29% of the company’s stock.

Phreesia Company Profile (NYSE:PHR)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.

Featured Stories

Want More Great Investing Ideas?

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.